Anebulo Pharmaceuticals
ANEBNasdaq United States
Market cap
—
Revenue
—
Not reported
Earnings
-$8.48M
Loss-making
Shares outstanding
40,784,731
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Anebulo Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.